Funding Rounds
Noema Pharma

Noema Pharma Series B (2023, $110M)

Noema Pharma

Clinical-stage central nervous system (CNS) technology.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $110.29M

Raised Date: 2023-07-01

Investors